OPEN TRIAL OF THE OMEGA-3 FATTY ACID, EICOSAPENTAENOIC ACID, IN 10 PATIENTS WITH REFRACTORY EPILEPSY

被引：0
|
作者：
Yuen, A. W. [1 ]
Flugel, D. [2 ]
Poepel, A. [3 ]
Bell, G. S. [1 ]
Sander, J. W. [1 ,4 ]
机构：
[1] UCL Inst Neurol, London, England
[2] Kantonsspital St Gallen, St Gallen, Switzerland
[3] Schweizer Epilepsiezentrum, Zurich, Switzerland
[4] SEIN Epilepsy Inst Netherlands Fdn, Heemstede, Netherlands
来源：
EPILEPSIA | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy
    Yuen, Alan W. C.
    Flugel, Dominique
    Poepel, Annkathrin
    Bell, Gail S.
    Peacock, Janet L.
    Sander, Josemir W.
    EPILEPSY & BEHAVIOR, 2012, 23 (03) : 370 - 372
  • [2] Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial
    Yuen, AWC
    Sander, JW
    Fluegel, D
    Patsalos, PN
    Bell, GS
    Johnson, T
    Koepp, MJ
    EPILEPSY & BEHAVIOR, 2005, 7 (02) : 253 - 258
  • [3] Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid in the Treatment of Depression
    Jazayeri, S.
    Keshavarz, S. A.
    Tehranidoost, M.
    Jalali, M.
    Hosseini, M.
    Djazayery, A.
    Amini, H.
    Chamari, M.
    Peet, M.
    JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2008, 1 (1-2) : 78 - 78
  • [4] Effect of omega-3 fatty acid supplementation on the arachidonic acid: Eicosapentaenoic acid ratio
    Burns, Tammy
    Madejewski, Stephanie R.
    Hamilton, William R.
    Zheng, Margaret
    Mooss, Aryan N.
    Hilleman, Daniel E.
    PHARMACOTHERAPY, 2007, 27 (05): : 633 - 638
  • [5] Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
    Mason, R. Preston
    Libby, Peter
    Bhatt, Deepak L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (05) : 1135 - 1147
  • [6] Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid
    Cockbain, Andrew J.
    Volpato, Milene
    Race, Amanda D.
    Munarini, Alessandra
    Fazio, Chiara
    Belluzzi, Andrea
    Loadman, Paul M.
    Toogood, Giles J.
    Hull, Mark A.
    GUT, 2014, 63 (11) : 1760 - 1768
  • [7] Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: Results from a randomized, placebo-controlled trial
    Emsley, Robin
    Niehaus, Dana J. H.
    Oosthuizen, Petrus P.
    Koen, Liez
    Ascott-Evans, Brynne
    Chiliza, Bonginkosi
    van Rensburg, Susan J.
    Smit, Retha M.
    PSYCHIATRY RESEARCH, 2008, 161 (03) : 284 - 291
  • [8] EFFECTS OF FLUOXETINE WITH AND WITHOUT OMEGA-3 FATTY ACID EICOSAPENTAENOIC ACID ON CARDIOVASCULAR DISEASE RISK IN DEPRESSIVE PATIENTS
    Djazayeri, Shima
    Keshavarz, Seyed Ali
    Tehrani-Doost, Mehdi
    Hosseini, Mostafa
    Jalali, Mahmoud
    Amini, Homayoun
    Chamari, Maryam
    Djazayery, Abolghassem
    ARYA ATHEROSCLEROSIS, 2007, 3 (03) : 151 - 156
  • [9] Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid in the Management of Hypercalciuric Stone Formers
    Ortiz-Alvarado, Omar
    Miyaoka, Ricardo
    Kriedberg, Carly
    Leavitt, David A.
    Moeding, Angela
    Stessman, Michelle
    Monga, Manoj
    UROLOGY, 2012, 79 (02) : 282 - 286
  • [10] Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
    Brinton, Eliot A.
    Mason, R. Preston
    LIPIDS IN HEALTH AND DISEASE, 2017, 16 : 1 - 13
12345